Diopsys Company Profile

18:45 EDT 16th October 2018 | BioPortfolio

News Articles [4 Associated News Articles listed on BioPortfolio]

Diopsys unveils two electrophysiology testing products at ASCRS

WASHINGTON — Diopsys will introduce two new visual electrophysiology testing products at the American Society of Cataract and Refractive Surgery meeting.The Retina Plus is a carry-case-sized device ...

Diopsys Introduces New Screening Test That Helps Identify Retinal Dysfunction Associated with Diabetic Eye Disease

The Diopsys® Chromatic Flash Vision Screener is a simple-to-use and easy-to-integrate protocol within the Diopsys® ffERG / Full Field Electroretinography module. PINE BROOK, N.J. (PRWEB) Oct...

Diopsys Introduces the Latest in Electrophysiology Testing At ASCRS

RETINA PLUS and multifocal electroretinography (mfERG) will offer eye care experts access to powerful new tools for understanding the health of the retina. PINE BROOK, N.J. (PRWEB) April 13, 2018 Dio...

Another Study Highlights the Important Role of PERG in Evaluation of Manifest and Suspected Glaucoma

Clinic-based pattern electroretinography (PERG) from Diopsys equips eye care specialists with actionable information for better, timelier clinical decision making. PINE BROOK, N.J. (PRWEB) May 08, 201...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Electroretinogram Pattern (Diopsys® NOVA System) for the Early Diagnosis of Glaucoma

Glaucoma is a common and potentially blinding disease. It is characterized by an optic nerve damage, a visual field defect and elevated intraocular pressure (IOP). The loss of retinal ner...

Management of Glaucoma w/ SLT or Trabecular Stent Bypass Microsurgery Using the Diopsys VEP/PERG Protocols

The purpose of this study is to establish electrophysiological benchmarks, using the Diopsys Visual Evoked Potential/ Pattern Electroretinogram (VEP/PERG) protocols of populations with Gla...

Are There Changes in the Nerve Fiber Layer (NFL) After Lowering of Eye Pressure?

The aim of this study was to evaluate structural and functional improvement following intraocular pressure (IOP) reductions in patients with glaucoma using Spectral Domain Optical Coherenc...

More Information about "Diopsys" on BioPortfolio

We have published hundreds of Diopsys news stories on BioPortfolio along with dozens of Diopsys Clinical Trials and PubMed Articles about Diopsys for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Diopsys Companies in our database. You can also find out about relevant Diopsys Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record